Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population

INTRODUCTION: In patients with hepatitis C virus (HCV), human immunodeficiency virus (HIV) represents a major cause of morbidity and economic burden. Economic evaluations in HIV-HCV typically focus on government-sponsored insurance plans rather than a commercially insured cohort. This study evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattingly, T. Joseph, Pandit, Neha S., Onukwugha, Eberechukwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522558/
https://www.ncbi.nlm.nih.gov/pubmed/30825134
http://dx.doi.org/10.1007/s40121-019-0240-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522558/
https://www.ncbi.nlm.nih.gov/pubmed/30825134
http://dx.doi.org/10.1007/s40121-019-0240-7

Ejemplares similares